Source: BioPortfolio

True North Therapeutics: True North Expands Leadership Team to Advance Pipeline of Novel Rare Disease Treatments Targeting the Complement System

Adds Experienced Biotechnology Executives with Regulatory Commercial and Clinical Expertise True North Therapeutics a clinical stage biotechnology company developing novel product candidates that selectively inhibit the Com...

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
1-25
Nancy Stagliano's photo - Co-Founder & CEO of True North Therapeutics

Co-Founder & CEO

Nancy Stagliano

CEO Approval Rating

71/100

Read more